For years, Parkinson’s disease was framed as a strictly brain-based problem.
Now, researchers are turning their gaze toward the mouth.
New work suggests that a common oral bacterium, usually blamed for cavities, may quietly set off a chain reaction that reaches the brain. If confirmed, the findings could reshape how doctors think about Parkinson’s, and put everyday dental care on the list of possible prevention tools.
A familiar cavity bacterium under suspicion
Scientists have long struggled to pinpoint what truly sparks Parkinson’s disease. Genes explain only a fraction of cases. Age, pesticides and air pollution have all been suggested, but no single culprit fully fits the puzzle.
A recent study, published in 2025 in the journal Nature Communications and reported by SciTechDaily, adds an unexpected character: Streptococcus mutans, a bacterium better known for causing tooth decay.
Researchers found that a strain of Streptococcus mutans may migrate from the mouth to the gut, where it produces compounds capable of damaging brain cells.
Instead of staying locked in the dental plaque that coats teeth, this microbe can, in some people, colonise the intestine. Once settled there, it appears more frequently in individuals living with Parkinson’s than in people of the same age without the disease.
This finding feeds into a broader idea gaining traction in neurology: that Parkinson’s might begin outside the brain, with early signals travelling along what scientists are calling the “mouth–gut–brain axis”.
From molars to neurons: how the mouth–gut–brain axis might work
The new research focuses on a chemical chain reaction set off by Streptococcus mutans in the gut. After it embeds in the intestinal microbiome, the bacterium produces a specific enzyme. That enzyme, in turn, generates a small molecule with a big impact: imidazole propionate.
Imidazole propionate does not stay local. It seeps through the gut wall, enters the bloodstream and circulates through the body. Crucially, the study suggests that it can cross the blood–brain barrier, a normally tight shield that protects brain tissue from many circulating substances.
Once inside the brain, imidazole propionate appears to overstimulate a key cell-survival pathway known as mTORC1, leaving neurons more vulnerable to damage.
➡️ The crucial move to make before putting your bank card into an ATM to avoid being scammed
➡️ 3 high-protein foods to protect muscle mass after 50 (without meat or cured meats)
➡️ Here Are The 10 Most Powerful Air Forces In The World In 2025 – And France Is Second To Last
➡️ The Epstein-Barr virus may play a key role in autoimmune diseases
➡️ Neither chess nor crosswords: the best activity to keep your brain sharp after 60
In animal experiments, exposure to this metabolite triggered changes that closely mirror human Parkinson’s:
- gradual loss of dopamine-producing neurons in brain regions that control movement
- signs of brain inflammation, with immune cells switching into a more aggressive state
- abnormal build-up of alpha-synuclein, a protein that clumps inside neurons and is a hallmark of Parkinson’s pathology
These observations suggest that certain bacteria, through the molecules they excrete, could speed up degeneration already underway or even help start it.
The role of dopamine and alpha-synuclein
Parkinson’s symptoms, such as tremors, slowness and rigidity, arise when dopamine-producing neurons in a deep brain area called the substantia nigra begin to die off. Dopamine acts like a chemical messenger for smooth, coordinated movement.
At the same time, many patients show clumps of a protein called alpha-synuclein in their brain cells. Those clumps can spread from cell to cell, disrupting normal function. The new study links the bacterial metabolite to both dopamine loss and alpha-synuclein build-up, adding another layer to the story.
The proposed pathway ties together gut bacteria, abnormal protein accumulation and the death of dopamine neurons into a single biological narrative.
MTORC1: a traffic controller gone into overdrive
The mTORC1 pathway acts as a kind of traffic controller inside cells. It helps decide when a cell should grow, when it should recycle damaged components and how it responds to stress.
When imidazole propionate chronically activates mTORC1, neurons seem to lose their balance. Their ability to clear out faulty proteins drops, while stress signals intensify. In the animal models used by the team, blocking mTORC1 reduced brain lesions and improved movement, suggesting that this pathway could be a future drug target.
What this means for future treatments
If these findings hold in humans, scientists could try several strategies:
| Approach | Potential goal |
|---|---|
| Targeting Streptococcus mutans in the mouth | Reduce the number of bacteria that can migrate to the gut |
| Modifying the gut microbiome | Limit colonisation by harmful strains and support protective microbes |
| Blocking imidazole propionate | Prevent the metabolite from reaching or acting in the brain |
| Modulating mTORC1 activity | Protect neurons by restoring more normal cellular signalling |
Oral hygiene as a possible line of defence
The idea that toothbrushing might one day appear in Parkinson’s prevention guidelines sounds surprising, yet the logic is straightforward. Streptococcus mutans thrives in sticky dental plaque and feeds on sugar. When numbers stay high for years, the odds that some of these bacteria reach the gut may rise as well.
Keeping dental plaque under control could, in theory, cut off one potential source of harmful gut colonisation linked to Parkinson’s processes.
Good oral hygiene routines already reduce cavities, gum disease and tooth loss. If Parkinson’s risk turns out to be part of the package, the case for regular brushing and dental check-ups grows even stronger.
Simple steps that dentists already recommend include:
- brushing teeth twice daily with fluoride toothpaste
- cleaning between the teeth with floss or interdental brushes
- limiting frequent sugary snacks and drinks that feed cavity bacteria
- visiting a dentist or hygienist regularly for tartar removal and early treatment
People who already live with Parkinson’s often struggle with oral care because of tremors and reduced dexterity. Electric toothbrushes, thicker-handled brushes and help from carers can make a difference and may indirectly influence gut health as well.
What patients and families should know right now
Researchers stress that this work describes a possible mechanism, not a guaranteed cause. Not everyone with poor oral hygiene will develop Parkinson’s. Not everyone with Parkinson’s will carry the same bacterial strain. Genetic makeup, environmental exposures and ageing still play major roles.
That said, the findings hint that certain combinations can increase vulnerability. For instance, someone with a Parkinson’s-prone genetic profile, long-standing dental problems and a microbiome rich in Streptococcus mutans may face a higher risk than each factor alone would suggest.
The emerging picture is one of cumulative effects: genes, bacteria, lifestyle and age interacting over many years before the first tremor appears.
For people worried about their risk, focusing on what can be controlled makes sense. Smoking cessation, regular exercise, a varied diet rich in fibre and vegetables, and careful management of pesticides at home or work all appear to support brain and gut health. Adding consistent dental care to that list is a low-cost, low-risk step.
Key terms behind the headlines
Several technical phrases keep appearing in this research. A short glossary can help clarify them:
- Microbiome: the community of bacteria, fungi and other microbes that live on and inside the body, especially in the gut.
- Blood–brain barrier: a protective layer of cells lining brain blood vessels that filters what can pass from the blood into brain tissue.
- Metabolite: a small molecule produced when organisms, including bacteria, break down or transform nutrients.
- mTORC1 pathway: a signalling network inside cells that controls growth, energy use and recycling of cellular components.
Future studies will need to track large groups of people over time, testing their oral bacteria, gut microbes and blood metabolites long before Parkinson’s appears. That kind of work takes years, but it could reveal which patterns of bacteria and metabolites most strongly predict disease.
Until those answers arrive, one message is already clear: the boundaries between dental care, gut health and brain disease are much more porous than previously thought. A small bacterium on a tooth surface may be more deeply connected to the brain than anyone expected a decade ago.
Originally posted 2026-02-06 17:46:47.